Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 82.83% |
| 2 | Healthcare | 3.13% |
| 3 | Technology | 2.97% |
| 4 | Financials | 2.19% |
| 5 | Consumer Discretionary | 2.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
12276
PUT
Hippo Holdings
HIPO
$857M
| $53.5K | ﹤0.01% |
2,000
-6,800
| -77% | -$167K |
2023 Q4
4 quarters
|
|
|
VEEA
12277
Veea Inc
VEEA
$15.4M
| $53.5K | ﹤0.01% |
+702
| New | +$49.5K |
2024 Q4
0 quarters
|
|
12278
PUT
AirSculpt Technologies
AIRS
$134M
| $53.5K | ﹤0.01% |
+10,300
| New | +$63.2K |
2024 Q4
0 quarters
|
|
12279
CALL
Riskified
RSKD
$1.03B
| $53.4K | ﹤0.01% |
11,300
-16,800
| -60% | -$77.9K |
2021 Q4
12 quarters
|
|
12280
PUT
Tempest Therapeutics
TPST
$13.3M
| $53.4K | ﹤0.01% |
4,923
+723
| +17% | +$9.33K |
2023 Q4
4 quarters
|
|
12281
PUT
Grid Dynamics Holdings
GDYN
$634M
| $53.4K | ﹤0.01% |
2,400
+1,900
| +380% | +$33.2K |
2024 Q2
2 quarters
|
|
|
IAUX
12282
i-80 Gold Corp
IAUX
$1.39B
| $53.3K | ﹤0.01% |
+109,972
| New | +$88.9K |
2024 Q4
0 quarters
|
|
12283
CALL
OrthoPediatrics
KIDS
$593M
| $53.3K | ﹤0.01% |
2,300
-3,200
| -58% | -$80K |
2022 Q4
8 quarters
|
|
12284
CALL
W&T Offshore
WTI
$542M
| $53.3K | ﹤0.01% |
32,100
+4,800
| +18% | +$9.59K |
2019 Q4
20 quarters
|
|
12285
CALL
iShares National Muni Bond ETF
MUB
$47.4B
| $53.3K | ﹤0.01% |
500
-200
| -29% | -$21.5K |
2024 Q3
1 quarter
|
|
12286
PUT
Xtrackers S&P 500 ESG ETF
SNPE
$2.86B
| $53.3K | ﹤0.01% |
1,000
+900
| +900% | +$48.4K |
2024 Q3
1 quarter
|
|
|
MAPS
12287
CALL
DELISTED
WM TECHNOLOGY INC A
MAPS
| $53.3K | ﹤0.01% |
38,600
-46,000
| -54% | -$49.5K |
2021 Q1
15 quarters
|
|
12288
CALL
Warby Parker
WRBY
$3.24B
| $53.3K | ﹤0.01% |
2,200
-16,400
| -88% | -$335K |
2021 Q4
12 quarters
|
|
12289
PUT
US Physical Therapy
USPH
$1.25B
| $53.2K | ﹤0.01% |
600
-1,500
| -71% | -$134K |
2022 Q2
10 quarters
|
|
|
YBIT
12290
PUT
YieldMax Bitcoin Option Income Strategy ETF
YBIT
$62.7M
| $53.2K | ﹤0.01% |
+860
| New | +$58K |
2024 Q4
0 quarters
|
|
|
IMMP
12291
PUT
Immutep
IMMP
$32M
| $53.2K | ﹤0.01% |
1,225
+90
| +8% | +$3.62K |
2021 Q4
12 quarters
|
|
12292
CALL
State Street SPDR S&P Health Care Equipment ETF
XHE
$181M
| $53.1K | ﹤0.01% |
600
-300
| -33% | -$26.9K |
2022 Q4
8 quarters
|
|
12293
PUT
Gorman-Rupp
GRC
$2.04B
| $53.1K | ﹤0.01% |
1,400
+700
| +100% | +$28K |
2022 Q4
8 quarters
|
|
12294
PUT
CareCloud
CCLD
$88M
| $53.1K | ﹤0.01% |
14,500
+12,900
| +806% | +$38.3K |
2024 Q1
3 quarters
|
|
|
ZKH
12295
ZKH Group
ZKH
$387M
| $53K | ﹤0.01% |
+15,110
| New | +$55.1K |
2024 Q4
0 quarters
|
|
12296
PUT
Standard BioTools
LAB
$283M
| $53K | ﹤0.01% |
30,300
+16,200
| +115% | +$30.2K |
2023 Q3
5 quarters
|
|
12297
CALL
Airgain
AIRG
$55.2M
| $53K | ﹤0.01% |
7,500
+5,500
| +275% | +$48.1K |
2023 Q3
5 quarters
|
|
12298
CALL
Invesco DB Oil Fund
DBO
$285M
| $52.9K | ﹤0.01% |
3,700
+1,200
| +48% | +$17.4K |
2022 Q1
11 quarters
|
|
|
FWDI
12299
Forward Industries Inc
FWDI
$621M
| $52.9K | ﹤0.01% |
+10,705
| New | +$43.1K |
2024 Q4
0 quarters
|
|
12300
CALL
Tyra Biosciences
TYRA
$1.39B
| $52.8K | ﹤0.01% |
3,800
-17,800
| -82% | -$323K |
2024 Q3
1 quarter
|
|
Similar funds
Citadel Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Citadel Advisors held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors's Q4 2024 filing shows 1,745 new, 6,427 increased, 6,082 reduced and 1,421 closed positions. Its largest new stake was Zoetis: 1,090,499 shares worth $178M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, down from 83% a quarter earlier, followed by Healthcare and Technology.
- Citadel Advisors's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Citadel Advisors added most to Boeing in Q4 2024, an estimated $830M increase.
- Citadel Advisors's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Citadel Advisors fully exited Spotify in Q4 2024, selling an estimated $473M.
- Citadel Advisors's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Citadel Advisors opened 1,745 new positions and closed 1,421 in Q4 2024.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.